AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

FDA Approves BRAFTOVI® Combination Regimen as First-Line Treatment for BRAF V600E-Mutant Metastatic Colorectal Cancer

The Role of Big Data in Precision Medicine

Caris Life Sciences Celebrates 1,000+ Precision Medicine Studies, Advancing Cancer Research and Patient Outcomes

OncoHelix and Qualisure Diagnostics Partner to Bring Thyroid GuidePx® Test to Canadian Patients

Gates Foundation Invests $50 Million in Tessera Therapeutics to Advance Gene Therapy for Sickle Cell Disease

FDA Approves Ensartinib (Ensacove) as First-Line Treatment for ALK-Positive NSCLC

Guardant Health and Boehringer Ingelheim Collaborate to Advance Liquid Biopsy CDx for HER2-Targeted Therapy in NSCLC

Cartherics Receives $300K G-Rex Grant to Advance Cancer Cell Therapy Manufacturing

Roche Revolutionizes Mass Spectrometry Diagnostics with Launch of cobas® Mass Spec Solution

Complete Genomics Partners with Eurofins Clinical Enterprise to Expand Sequencing Service Offerings

NeuroKaire Secures $10M to Transform Precision Medicine in Psychiatry and Neurology

Home
/
update
/
details

Skanray and Tata Elxsi Collaborate to Innovate Surgical Imaging and Healthcare Solutions

NextEdge Admin

06 Aug 2024

2 min 34 sec

Skanray, a global leader in MedTech R&D and manufacturing, specializing in diagnostic imaging, critical care, and surgical solutions, has partnered with Tata Elxsi to develop advanced surgical imaging core technology and software platforms. This collaboration aims to revolutionize diagnosis and treatment by leveraging cutting-edge technology for predictability, accuracy, and consistency.

Skanray is expanding its portfolio to include new device families and modalities, focusing on building reusable modules and components for medical devices and developing an advanced analytics cloud platform.

Tata Elxsi will spearhead a software platform-led approach to diagnostics, supporting all imaging, critical care, and surgical systems from Skanray, ensuring interoperability and multi-modal functionality. The platform will incorporate the latest AI and GenAI technologies and process efficiencies.

This collaboration combines Skanray's expertise in medical devices and core component technology with Tata Elxsi's domain experience in medical imaging, software platform development, digital capabilities in cloud, AI, and analytics. This synergy aims to redefine the medical technology landscape with advanced, modular, and affordable diagnostic systems.

Pankaj Madhukar Wani, Head of Healthcare Business Unit at Tata Elxsi, stated, "The diagnostic imaging landscape is being transformed by software and digital technologies such as cloud and AI. We are delighted to support Skanray in realizing their long-term strategy and vision for healthcare. This partnership will create transformative solutions for healthcare facilities and patients worldwide."

Priyanka Chatterjee, VP – Corporate Communications at Skanray Technologies Ltd., added, "Our collaboration will drive significant advancements in healthcare delivery, resulting in technologically advanced, operator-friendly, and cost-effective solutions, helping healthcare providers deliver significantly improved health outcomes for patients."